Global Prevalence, Patient and Economic Burden of Presbyopia: A Systematic Literature Review | ASCRS
Presentation
Global Prevalence, Patient and Economic Burden of Presbyopia: A Systematic Literature Review
May 2020
Meeting: 2020 Virtual Annual Meeting
Session: SPS-107 Presbyopia Correction II
Authors: John P. Berdahl, MD, Chandra Bala PhD, MBBS, FRANZCO, Shantanu Jawla MS, Mukesh Dhariwal MBBS, MPH, Jessie Lemp-Hull PhD
You do not have access to this library

This content is accessible only to 2020 ASCRS Virtual Annual Meeting attendees. If you attended the virtual meeting, please log in with the account associated with your virtual meeting registration.  To log in, click the teal "Login" button in the upper right-hand corner of this page.

Purpose
Presbyopia is an impairment of near vision characterized by gradual loss of the ability of the eyes to focus on nearby objects, and pose burden to patients and healthcare systems. The objective of the present study was to collate and report published evidence on presbyopia burden (prevalence, impact on patient quality of life and associated costs).

Methods
A systematic search was conducted in the MEDLINE®, Embase®, and Cochrane Library databases from the time of inception through October 2018. Studies published in the English language reporting the epidemiology and patient and economic burden of presbyopia were included. Overall, 64 studies were included for data extraction and reporting.

Results
Global prevalence of presbyopia is predicted to increase from 1.1 billion in 2015 to 1.8 billion by 2050. In 2010, 89% of adults ≥45 years in the United States (US) suffered from presbyopia. Uncorrected presbyopia increases odds of difficulty in performing near-vision tasks and very demanding near-vision tasks by 2-fold and >8-fold respectively. Uncorrected Presbyopia combined with uncorrected distance vision impairment significantly affects patients’ quality of life. Globally, the potential productivity loss due to uncorrected or under-corrected presbyopia in individuals aged <50 years is estimated to be US $11 billion [0.02% of the global Gross Domestic Product].

Conclusion
Presbyopia poses significant burden to societies, and requires timely and optimal correction to minimize impact on vision quality and productivity.
View More Presentations from this Session

This presentation is from the session "SPS-107 Presbyopia Correction II" from the 2020 ASCRS Virtual Annual Meeting held on May 16-17, 2020.

We use cookies to measure site performance and improve your experience. By continuing to use this site, you agree to our Privacy Policy and Legal Notice.